genome

Two scientists in a lab looking at a tablet
Anne Wojcicki will acquire 23andMe for $305M following bankruptcy
By Jessica Hagen | 12:51 pm | June 16, 2025
Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.
Scientist in a laboratory
BC researchers receive $49M for genomics projects
By Anthony Vecchione | 12:27 pm | April 03, 2025
The projects will make use of genome sequencing data for more personalized, preventative and cost-effective healthcare.
Employees meeting in a conference room
Qi Biodesign secures $75M for genome editing technology
By Anthony Vecchione | 01:32 pm | December 10, 2024
The company will use the funds to enhance its R&D strategy, advance its SEEDIT platform and boost product development.  
With PerkinElmer and Northshore deals, personal genomics company Helix gets more clinical
By Jonah Comstock | 03:42 pm | April 12, 2018
Personal genomics company Helix announced two new partnerships this week, both of which take the company — which has focused on ancestry and lifestyle applications in the past — strongly into the clinical realm.